E-MTAB-223 - ChIP-Seq of human breast cancer cell lines with antibodies FOXA1, ER and CTCF
Status | Released on 1 February 2011, last updated on 30 October 2013 | ||||||||||
Organism | Homo sapiens | ||||||||||
Samples (53) | |||||||||||
Protocols (4) | |||||||||||
Description | Growth cells and map of ER, FoxA1 and CTCF binding at whole genome level | ||||||||||
Experiment types | ChIP-seq, high throughput sequencing, binding site identification | ||||||||||
Contact | |||||||||||
Citations | FOXA1 is a key determinant of estrogen receptor function and endocrine response. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. Nat Genet 43(1):27-33 (2011), PMID:21151129 Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties. Serandour AA, Brown GD, Cohen JD, Carroll JS. :R147 (2013), PMID:24373287 | ||||||||||
MINSEQE |
| ||||||||||
Files |
| ||||||||||
Links |